Oncology Resource Group
Market ResearchView the employees at
Oncology Resource Group-
Cara Lang, Ph.D. Disease Area Analyst | Ovarian Cancer | ImmunoOncology | Oncology Resource Group
-
Nashville
-
Rising Star
Amanda Lanser, Ph.D. Competitive Intelligence | Pharma Strategy | Oncology-
Greater Boston
-
Rising Star
Patrick Nygren, Ph.D. Director, Hematology Team at Oncology Resource Group-
Portland, Oregon, United States
-
Rising Star
Carla Cabrera Ph.D. Senior Manager, ADCs & Breast Cancer-
Washington, District of Columbia, United States
-
Top 5%
Amber Mineo Ph.D. Competitive Intelligence | Business Analyst | Medical Writer | GI Tumor | Oncology Product Development | Project Management | Team Leadership | Cyclist-
Portland, Oregon, United States
-
Rising Star
Overview
Oncology Resource Group serves pharmaceutical and biotechnology developers worldwide by delivering best-in-class market planning and competitive intelligence reports through ONCrg's expert advisors in solid tumor, hematologic malignancy, emerging + late stage immuno-oncology, and MOA drug markets. ONCrg was founded by senior consultants, Stacey McCann and Michael D. Reynolds, with a vision to add value to client programs through focused expertise in oncology drug markets and broader and deeper market planning resources than our competitors; where their capabilities are attenuated by working in too many non-drug and non-oncology market sectors. Our fundamental belief is that clients are better served by putting all of our firm’s analytical efforts and capabilities behind the exclusive study of oncology markets so we can deliver market planning resources with more depth, insight, and precision than would otherwise be possible. We are committed to helping our clients succeed in creating winning strategies and making the right business decisions for their new products, brands, franchises, partnerships, and alliances. By empowering talented consultants that intensely focus on oncology drug markets, and working hand-in-hand with clients to develop the most relevant forward-looking resources possible, we achieve new standards of analytical excellence and deliver the most accurate, insightful, and robust market planning resources available anywhere in this challenging and pivotal healthcare arena.
-